Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 201.90
+3.00 (1.51%)
At close: Jul 27, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 9.75 billion as of July 27, 2026. Its market cap has increased by 16.81% in one year.
Market Cap
9.75B
Enterprise Value
11.27B
Revenue
6.81B
Ranking
n/a
PE Ratio
37.89
Stock Price
201.90
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 9.75B, an increase of 1,604.35%. That is a compound annual growth rate of 12.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 9.75B | 34.69% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 14.80B |
| Shukra Pharmaceuticals | 13.94B |
| Fermenta Biotech | 12.73B |
| Syncom Formulations (India) | 12.31B |
| Lincoln Pharmaceuticals | 11.63B |
| Wanbury | 11.56B |
| Sudarshan Pharma Industries | 10.06B |
| Bharat Parenterals | 9.90B |